Medmix AG (XSWX:MEDX) Debt-to-EBITDA : 5.36 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Medmix AG Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Medmix AG's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF42.2 Mil. Medmix AG's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was CHF307.5 Mil. Medmix AG's annualized EBITDA for the quarter that ended in Dec. 2023 was CHF65.2 Mil. Medmix AG's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 5.36.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Medmix AG's Debt-to-EBITDA or its related term are showing as below:

XSWX:MEDX' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 2.45 Med: 4.15 Max: 6.79
Current: 4.9

During the past 6 years, the highest Debt-to-EBITDA Ratio of Medmix AG was 6.79. The lowest was 2.45. And the median was 4.15.

XSWX:MEDX's Debt-to-EBITDA is ranked worse than
79.77% of 2303 companies
in the Industrial Products industry
Industry Median: 1.74 vs XSWX:MEDX: 4.90

Medmix AG Debt-to-EBITDA Historical Data

The historical data trend for Medmix AG's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medmix AG Debt-to-EBITDA Chart

Medmix AG Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

Get a 7-Day Free Trial

3.40

5.42

2.89

6.79

4.90

Medmix AG Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial					2.97	3.95	8.37	4.08	5.36

Competitive Comparison of Medmix AG's Debt-to-EBITDA

For the Specialty Industrial Machinery subindustry, Medmix AG's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medmix AG's Debt-to-EBITDA Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Medmix AG's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Medmix AG's Debt-to-EBITDA falls into.

Medmix AG Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Medmix AG's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(42.2	+	307.5)	/	71.4
	=	4.90

Medmix AG's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(42.2	+	307.5)	/	65.2
	=	5.36

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.

Medmix AG (XSWX:MEDX) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Medmix AG Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Medmix AG's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Medmix AG (XSWX:MEDX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Medmix AG (XSWX:MEDX) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

MDMXF:USA MEDXz:UK

Address

Dammstrasse 19, Baar, Zug, CHE, 6340

Website

https://www.medmix.swiss

Medmix AG delivers technologies in high-precision delivery devices and fluid mixing for applications. It is into two business areas Healthcare and Consumer & Industrial. The Healthcare business area is divided into the Dental, Drug Delivery and Surgery segments. The Consumer & Industrial business area operates through the Industry and Beauty segments. The majority of revenue is from Consumer & Industrial segment. In the Industry segment, dispensers, cartridges, and mixers are used in the construction, transportation (automotive, railways and aerospace), electronics assembly, infrastructure and DIY industries. Geographically, it operates in Europe the Middle East and Africa, the Americas and Asia-Pacific.